Search

Filters
Clear All
  • 16
  • 49
  • 637

Phase

  • 17
  • 16
  • 53
  • 5
  • 75
  • 5
  • 521
  • 621
  • 289
  • 689
  • 13

Found 702 in-health trials

A listing of in-health medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

D
David Koceja, PhD
18 years - 70 years
Accepts healthy volunteer
All genders
The purpose of the study is to explore how visual input impacts the neural mechanisms at the spinal level relating to posture during quiet standing. It is known that static visual input (for example eyes open vs eyes closed) can impact the magnitude of the spinal reflexes. It is also …
S
Sandeep Batra, MD
1 year - 25 years
All genders
Phase 3
Interventional
This study investigates the effectiveness of adding an investigational medication to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL). It also examines outcomes for patients with mixed phenotype acute leukemia (MPAL) and B-lymphoblastic lymphoma (B-LLy) treated with standard chemotherapy. B-ALL is a type of cancer that affects …
R
Robert Tepper, MD
6 months - 11 years
All genders
Observational
In a randomized clinical trial (RCT) published in JAMA, the investigators have providedvidence that vitamin C supplementation (500 mg daily during pregnancy) ameliorates theking during pregnancy on offspring lung function and subsequentdence of wheeze by 48% through 1 year of age. The investigators are currently completingd RCT of vitamin C …
T
Tarah Ballinger, MD
18 years - 100 years
All genders
This study investigates the connection between stress, race, and breast cancer. Breast cancer is a disease where cells in the breast grow uncontrollably. The study looks at how stress and racial differences may affect breast cancer types and outcomes.Participants will be part of two groups: one to develop a stress …
S
Sandeep Batra, MD
3 years - 30 years
All genders
Phase 2
What is the purpose of this study?This phase II trial studies how well lower dose radiotherapy after chemotherapy works in treating children with central nervous system (CNS) germinomas. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Carboplatin is in a class …
S
Stacey Tarvin, MD
21 years or below
All genders
Observational
This study investigates how childhood-onset neuropsychiatric systemic lupus erythematosus (NPSLE) affects cognitive functions over time. Systemic lupus erythematosus (SLE) is a disease where the immune system attacks the body, causing inflammation and damage. The study uses a tool called pedANAM to assess cognitive and behavioral functions in children with this …
E
Erik David Andrewski
12 years - 17 years
All genders
Interventional
This study investigates the effects of an investigational medication for treating Irritable Bowel Syndrome with Constipation (IBS-C) in teenagers. IBS-C is a condition where the belly hurts and there is trouble going to the bathroom. This study is for children aged 12 to less than 18 years old.During the study, …
Y
Yunjie Lin, MD
R
Richard Zellars, MD
40 years - 100 years
Female
This study investigates the effects of receiving regional radiotherapy compared to no regional radiotherapy in patients with low risk node positive breast cancer. Breast cancer is a disease where cells in the breast grow uncontrollably. This study includes two study arms. In one arm, participants who had breast conserving surgery …
K
Karl Shively
L
Luke A. Lopas, MD
18 years - 64 years
All genders
Phase 3
Interventional
The proposed study is a multi-center, prospective randomized controlled trial comparingurrent standard of care treatment to the SEXTANT treatment protocol in patients with Typeures of the tibia and IIIB fractures of the ankle and hindfoot.
S
Sandeep Batra, MD
21 years or below
All genders
Phase 3
Interventional
What is the purpose of this study?This phase III trial compares standard chemotherapy to therapy with liposome-encapsulated daunorubicin-cytarabine (CPX-351) and/or gilteritinib for patients with newly diagnosed acuteyeloid leukemia with or without FLT3 mutations. Drugs used in chemotherapy, such as daunorubicin, cytarabine, and gemtuzumab ozogamicin, work in different ways to stop …
551 - 560 of 702